{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:59:09Z","timestamp":1790780349551,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.05.1388","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:10:04Z","timestamp":1747422604000},"page":"827-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced liver disease incidence in psoriasis patients treated with interleukin-23 inhibitors: A longitudinal cohort analysis"],"prefix":"10.1016","volume":"93","author":[{"given":"Arjun","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela S.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2025.05.1388_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaad.2024.09.063","article-title":"Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared with biologic-na\u00efve patients with psoriasis: a retrospective cohort study","volume":"92","author":"Ormaza Vera","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.1388_bib2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","article-title":"Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study","volume":"138","author":"Ogdie","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.05.1388_bib3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/1346-8138.17277","article-title":"Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors","volume":"51","author":"Takeshima","year":"2024","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.1388_bib4","article-title":"Validated administrative data based ICD-10 algorithms for chronic conditions: a systematic review","volume":"72","author":"Kuang","year":"2024","journal-title":"J Epidemiol Popul Health"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1388_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000485","article-title":"ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies","volume":"7","author":"Hayward","year":"2020","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225021279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225021279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:07:31Z","timestamp":1755648451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225021279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0190962225021279"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.1388","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced liver disease incidence in psoriasis patients treated with interleukin-23 inhibitors: A longitudinal cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.1388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}